Surgical Snare Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Surgical Snare Market is Segmented by Usability (Reusable Surgical Snares, Single-Use Surgical Snares), by Shape (Oval, Crescent, and More), by Application (Gastrointestinal Endoscopy, Laparoscopy, and More), by End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), by Geography (North America, Europe, Asia-Pacific, and More).

Surgical Snare Market Size and Share

Surgical Snare Market (2025 - 2030)
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Surgical Snare Market Analysis by Mordor Intelligence

The surgical snare market stands at USD 1.67 billion in 2025 and is projected to reach USD 2.06 billion by 2030, reflecting a steady 4.38% CAGR. Growth aligns with rising colorectal-cancer screening volumes, broader adoption of AI-assisted detection systems, and the transition toward cold-snare polypectomy that improves safety profiles. Ambulatory surgery centers (ASCs) now perform 72% of United States procedures at 45-60% lower costs than hospital settings, sharply increasing demand for single-use snares. Demographic tailwinds from aging populations further sustain procedure volumes, while technology leaders differentiate through shape optimization and artificial intelligence rather than price competition. Quality-assurance challenges, including recent recalls of single-use guide sheath kits, underscore the need for robust clinical evidence and post-market surveillance to protect adoption trajectories.

Key Report Takeaways

  • By usability, single-use devices held 68.36% of the surgical snare market share in 2024; reusable devices lagged as infection-control priorities intensified.  
  • By application, gastrointestinal endoscopy commanded 64.72% revenue share in 2024, while urology endoscopy is forecast to expand at a 5.24% CAGR through 2030.  
  • By shape, oval designs led with 41.28% share in 2024; crescent designs are projected to grow at 4.73% CAGR to 2030.  
  • By end-user, hospitals accounted for 56.64% of 2024 revenue, whereas ASCs are advancing at a 5.42% CAGR on the back of procedure migration.  
  • By geography, North America contributed 43.26% of 2024 revenue; Asia-Pacific is the fastest-growing region at 5.76% CAGR through 2030.  

Segment Analysis

By Usability: Single-Use Dominance Reshapes Economics

Single-use devices captured 68.36% of the surgical snares market share in 2024. The segment should advance at 4.89% CAGR to 2030 as infection-control mandates override per-procedure cost concerns. Recent contamination incidents involving reusable endoscopes push purchasers toward disposable options. However, rising waste management costs and new European packaging rules effective August 2026 create sustainability pressures on single-use models. Cardinal Health collected 18.3 million single-use items for recycling in 2024, showcasing emerging circular-economy responses.

Reusable snares remain relevant in high-volume centers that operate validated sterilization workflows. These facilities highlight lower lifetime costs compared with the USD 797–USD 4,400 per procedure expense for single-use duodenoscopes. Yet EU Medical Device Regulation compliance raises ongoing testing costs for reusables, narrowing the savings gap. Given the current adoption curve, the surgical snares market size for single-use devices will surpass USD 1.3 billion by 2030, representing a majority of incremental revenue. Providers increasingly demand eco-friendly materials to mitigate landfill impact, prompting vendors to explore biodegradable polymers.

Surgical Snare Market: Market Share by Usability
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Shape: Oval Leadership Faces Crescent Innovation

Oval designs held 41.28% market share in 2024, underscoring physician familiarity and broad lesion applicability. Crescent designs, however, post the fastest 4.73% CAGR to 2030 due to superior capture efficiency in flat lesions and favorable ergonomics in the right colon. Early clinical evidence shows crescent snares improving complete resection rates for lateral spreading tumors. Vendors respond by integrating micro-serrated wire edges to enhance tissue grip.

Specialized shield and hexagonal shapes address niche anatomical scenarios but account for a smaller slice of the surgical snares market. The Exacto Cold Snare’s shield shape yielded 91% complete resection versus 79% for traditional ovals, highlighting the performance boost that shape optimization can deliver. Demand for AI-guided navigation systems could accelerate adoption of shape-specific snares because algorithms prefer devices with predictable curvature profiles. As these innovations mature, the surgical snares market size for crescent designs could reach USD 590 million by 2030.

By Application: GI Endoscopy Dominance Amid Urology Surge

Gastrointestinal endoscopy maintained 64.72% share in 2024, benefiting from guideline-expansion and high global colorectal-cancer incidence. Urology procedures form the fastest-growing application at 5.24% CAGR through 2030, propelled by rising stone disease prevalence and improved 4K visualization such as the camera launched by Olympus in September 2024. Laparoscopy and gynecology contribute steady growth, driven by minimally-invasive adoption across broader surgical indications.

Emerging AI software that identifies bladder lesions or common bile duct stones in real time will further lift demand in non-GI specialties. The surgical snares market size for urology could climb above USD 210 million by 2030 from a low base, diversifying revenue streams for established endoscopy brands. Application-specific snares, such as those optimized for flexible ureteroscopes, amplify competitive differentiation beyond generic GI solutions.

Surgical Snare Market: Market Share by Application
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By End-User: Hospital Leadership Challenged by ASC Growth

Hospitals delivered 56.64% of 2024 revenue due to complex case handling and established procurement contracts. Yet ASCs are projected to grow at a 5.42% CAGR through 2030 as 21% procedure volume migration is expected, totaling 44 million ASC cases by 2034. Specialty clinics focus on selective procedures like inflammatory bowel disease surveillance, preferring single-use snares that simplify inventory.

ASC buyers value standardized kits that shorten turnover times, reinforcing single-use momentum. Vendors that can supply bulk-priced yet premium-featured snares will capture this high-growth channel. Reimbursement parity initiatives and expanding covered procedure codes reinforce the case shift, narrowing cost differentials with hospitals and funneling incremental demand into the surgical snares market.

Geography Analysis

North America led with 43.26% of 2024 revenue, underpinned by mature screening programs, robust ASC infrastructure, and early adoption of AI decision support. Growth through 2030 sits at 4.2% as value-based care rewards high resection completeness and low complication rates.[3]ASC Focus, “ASC Procedure Migration Forecast,” ascfocus.org FDA scrutiny following safety recalls prompts providers to favor manufacturers with transparent real-world evidence. The surgical snare market size in North America is expected to exceed USD 830 million by 2030, with single-use penetration topping 75%.

Europe presents a sophisticated regulatory environment anchored by the EU Medical Device Regulation. Higher approval costs create competitive moats for compliant suppliers, while environmental policy drives recyclable packaging mandates starting 2026. Germany, France, and the Nordic region continue to invest in AI CADe systems, positioning the surgical snare market for steady 4.1% CAGR despite reimbursement headwinds. Hospitals increasingly sign multiyear strategic agreements to secure evidence-backed snare designs and training services.

Asia-Pacific posts the fastest 5.76% CAGR through 2030 due to infrastructure expansion and screening guideline adoption. China continues to pilot community screening programs, and Japan’s decision to reimburse AI colonoscopy tools in 2024 boosts technology demand. Cost sensitivity persists in Thailand and Indonesia, steering buyers toward value-engineered devices. Local manufacturing partnerships reduce import duties and strengthen regional competitiveness. By 2030, Asia-Pacific could contribute 30% of global surgical snare market revenue, narrowing the gap with North America.

Surgical Snare Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The surgical snare market displays moderate concentration. Olympus, Boston Scientific, and Cook Medical combine long tenures, comprehensive portfolios, and extensive clinical data to defend leadership. Olympus derived 63.8% of its FY 2025 sales, or ¥997.3 billion, from Endoscopic Solutions. Boston Scientific closed acquisitions worth USD 3.7 billion for Axonics and USD 1.26 billion for Silk Road Medical in 2024, signaling an appetite for consolidation that widens barriers to entry.

Emerging differentiation lies in AI-enabled detection, recyclable materials, and shape-specific performance. Mid-tier players such as CONMED and Merit Medical pursue niche indications and regional markets. CONMED posted USD 321.3 million revenue in Q1 2025 and raised full-year outlook on robust endoscopy growth. Karl Storz acquired Asensus Surgical in 2024 to secure robotic capability at USD 0.35 per share. Patent portfolios covering micro-serrated wire and low-friction coatings create tactical defenses against commoditization.

Pricing remains relatively stable as hospitals and ASCs prioritize proven safety over low cost. The 2025 recall of Olympus single-use guide sheath kits after 26 serious injuries underscores the importance of post-market vigilance. Firms that combine design innovation with clinical surveillance are best positioned to expand share. As AI integration and sustainability standards rise, competitive advantage will hinge on meeting both clinical and environmental benchmarks across the surgical snare market.

Surgical Snare Industry Leaders

  1. Cook Medical

  2. CONMED Corporation

  3. Medline Industries

  4. Olympus Corporation

  5. Boston Scientific Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Surgical Snare Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • January 2025: Olympus acquired Sur Medical SpA, its longstanding Chilean distributor, to establish direct presence in the Chilean market.
  • November 2024: American Journal of Gastroenterology published data showing 10.8% immediate bleeding with cold snare polypectomy versus 3.2% with hot snare techniques for pedunculated polyps ≤10 mm.
  • May 2024: Videogie reported favorable outcomes for bipolar hot snare polypectomy on intermediate lesions.
  • March 2024: STERIS study confirmed Exacto Cold Snare achieved 91% complete resection compared with 79% for conventional snares.

Table of Contents for Surgical Snare Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising preference for minimally-invasive surgeries
    • 4.2.2 Expansion of endoscopic ambulatory surgery centers
    • 4.2.3 Hospital investments in advanced endoscopy suites
    • 4.2.4 Intensifying colorectal-cancer screening programs
    • 4.2.5 Increasing adoption of cold-snare polypectomy techniques
    • 4.2.6 AI-enabled snare devices enhancing detection & resection efficiency
  • 4.3 Market Restraints
    • 4.3.1 Post-polypectomy bleeding & perforation risks
    • 4.3.2 Reimbursement cuts for GI endoscopy procedures
    • 4.3.3 Stringent approval pathway for single-use devices
    • 4.3.4 Shift toward endoscopic submucosal dissection tools
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Bargaining Power of Suppliers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Intensity of Competitive Rivalry

5. Market Size & Growth Forecasts (Value)

  • 5.1 By Usability
    • 5.1.1 Reusable Surgical Snares
    • 5.1.2 Single-Use Surgical Snares
  • 5.2 By Shape
    • 5.2.1 Oval
    • 5.2.2 Crescent
    • 5.2.3 Hexagonal
    • 5.2.4 Others
  • 5.3 By Application
    • 5.3.1 Gastrointestinal Endoscopy
    • 5.3.2 Laparoscopy
    • 5.3.3 Urology Endoscopy
    • 5.3.4 Gynecology / Obstetrics Endoscopy
    • 5.3.5 Others
  • 5.4 By End-User
    • 5.4.1 Hospitals
    • 5.4.2 Ambulatory Surgical Centers
    • 5.4.3 Specialty Clinics
  • 5.5 By Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global-level Overview, Market-level Overview, Core Segments, Financials, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
    • 6.3.1 Olympus Corporation
    • 6.3.2 Boston Scientific Corporation
    • 6.3.3 Cook Medical (Cook Group)
    • 6.3.4 CONMED Corporation
    • 6.3.5 Medline Industries
    • 6.3.6 Medtronic plc
    • 6.3.7 STERIS plc
    • 6.3.8 Merit Medical Systems
    • 6.3.9 HOYA Group – Pentax Medical
    • 6.3.10 Karl Storz SE & Co. KG
    • 6.3.11 Micro-Tech Endoscopy
    • 6.3.12 Endo-Flex GmbH
    • 6.3.13 Taewoong Medical Co. Ltd
    • 6.3.14 Medico’s Hirata Inc.
    • 6.3.15 EMED Endoscopy
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Surgical Snare Market Report Scope

As per the scope of the report, the surgical snare is a device used for eliminating polyps and another extended stalk of tissue growth by slicing them off at the base. This report is segmented by Usability, Application, End-user, and Geography.

By Usability Reusable Surgical Snares
Single-Use Surgical Snares
By Shape Oval
Crescent
Hexagonal
Others
By Application Gastrointestinal Endoscopy
Laparoscopy
Urology Endoscopy
Gynecology / Obstetrics Endoscopy
Others
By End-User Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
By Usability
Reusable Surgical Snares
Single-Use Surgical Snares
By Shape
Oval
Crescent
Hexagonal
Others
By Application
Gastrointestinal Endoscopy
Laparoscopy
Urology Endoscopy
Gynecology / Obstetrics Endoscopy
Others
By End-User
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current value of the surgical snare market?

The market is valued at USD 1.67 billion in 2025 and is projected to reach USD 2.06 billion by 2030 at a 4.38% CAGR.

Which segment dominates the surgical snare market?

Single-use snares lead with 68.36% share in 2024 due to strong infection-control preferences across hospitals and ASCs.

Which geographic region is growing the fastest?

Asia-Pacific posts the highest 5.76% CAGR through 2030 thanks to expanding screening programs and rising healthcare investments.

How do reimbursement trends affect the market?

A 2.83% Medicare fee schedule cut for 2025 pressures provider budgets, yet devices that show clear clinical benefits, such as AI-enabled systems, still secure premium reimbursement in select regions.

Page last updated on: June 29, 2025

Surgical Snare Market Report Snapshots

Compare market size and growth of Surgical Snare Market with other markets in Healthcare Industry